Condition
Secondary Progressive Multiple Sclerosis (SPMS) clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Secondary Progressive Multiple Sclerosis (SPMS) clinical trials that are recruiting, at sites in 38 countries (most in United States (2), Switzerland (2), Egypt (1)). By phase: Phase 2 (2), Phase 1/2 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 38Countries
Newest Secondary Progressive Multiple Sclerosis (SPMS) clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| SUN-627 in non-active SPMS/PPMS: a Phase 2a test in adults | Phase 2 | Tampa, Florida and 6 other locations | Recruiting | Sep 25, 2026 |
| TRX319 treatment for people with primary or secondary progressive multiple sclerosis | Phase 1/2 | La Jolla, California and 7 other locations | Recruiting | Mar 17, 2026 |
| Remibrutinib for secondary progressive multiple sclerosis | Phase 3 | Birmingham, Alabama and 295 other locations | Recruiting | Nov 6, 2025 |
| Rituximab's effects on cognitive and hand functions in secondary progressive multiple sclerosis | Phase 2 | Giza, Giza Governorate | Recruiting | Sep 19, 2024 |
| Imaging axonal damage and repair in multiple sclerosis | — | Basel | Recruiting | Jan 4, 2022 |
All recruiting trials (5)
-
SUN-627 in non-active SPMS/PPMS: a Phase 2a test in adults
This trial tests whether SUN-627 is safe and tolerable in adults with non-active primary or secondary progressive MS.
-
TRX319 treatment for people with primary or secondary progressive multiple sclerosis
This trial will test whether the experimental therapy TRX319, given with or without a short bendamustine pre-conditioning, is safe and can slow or improve disability in adults with primary or secondary progressive MS.
-
Remibrutinib for secondary progressive multiple sclerosis
This trial will try remibrutinib versus placebo to see if it slows disability progression in adults with secondary progressive multiple sclerosis.
-
Rituximab's effects on cognitive and hand functions in secondary progressive multiple sclerosis
This study is testing if the medication rituximab can help improve thinking and hand skills in people with secondary progressive multiple sclerosis who have significant disabilities.
-
Imaging axonal damage and repair in multiple sclerosis
This study is testing new MRI techniques to see how axons are damaged and repaired in people with multiple sclerosis over two years.
Related topics
Quick answers
How many Secondary Progressive Multiple Sclerosis (SPMS) clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 38 countries. The most sites are in United States (2 trials), Switzerland (2 trials), Egypt (1 trial), Argentina (1 trial), Australia (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 1/2: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.